Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Novo Nordisk: FDA diabetes-drug comment deferred
Marketwatch
Wed, 09/23/09 - 08:41 am
Novo Nordisk
FDA
diabetes
liraglutide
AstraZeneca Denied Drug’s Diabetes Link After Warning
Bloomberg
Tue, 09/22/09 - 08:36 pm
diabetes
AstraZeneca
Seroquel
antipsychotics
Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful
BNET Pharma
Mon, 09/21/09 - 05:23 pm
Effient
Onglyza
diabetes
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
Diabetes Medication May Get New Life as Cancer Treatment
WSJ Online
Mon, 09/14/09 - 08:13 pm
cancer
diabetes
metformin
Glugophase
Bristol-Myers Squibb
Amylin and Biocon say they will work together to develop diabetes drug combining 2 hormones
Yahoo/AP
Fri, 09/11/09 - 08:24 am
Amylin
Biocon
partnerships
diabetes
Takeda to begin cardiovascular outcomes trial for alogliptin to treat type 2 diabetes
Pharmabiz
Sat, 08/29/09 - 11:24 am
Takeda
alogliptin
diabetes
Takeda starting cardiovascular trial on diabetes drug SYR-322
Pharma Times, UK
Fri, 08/28/09 - 07:28 am
Takeda
diabetes
drug trials
SYR-322
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
InVivo
Wed, 08/19/09 - 07:27 am
diabetes
Onglyza
Bristol-Myers Squibb
AstraZeneca
Glaxo’s Avandia Has More Heart Risks Than Actos, Study Finds
Bloomberg
Wed, 08/19/09 - 06:24 am
GSK
Actos
Avandia
diabetes
Takeda
INTERVIEW: Novo Nordisk CFO Confident On US Victoza Launch
WSJ Online
Thu, 08/6/09 - 09:21 am
Victoza
Pharma CEOs
Novo Nordisk
diabetes
New Diabetes Drug Could Give Januvia Stiff Competition
Seeking Alpha
Tue, 08/4/09 - 07:50 am
Merck
diabetes
Januvia
Bristol-Myers Squibb
AstraZeneca
Takeda
Forest Labs
OSI Pharmaceuticals
Novartis
Onglyza
FDA approves new diabetes drug Onglyza
Yahoo/AP
Fri, 07/31/09 - 02:56 pm
FDA
diabetes
AstraZeneca
Onglyza
Bristol-Myers Squibb
Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Yahoo/MarketWire
Sun, 07/26/09 - 10:23 am
liraglutide
diabetes
Novo Nordisk
Sanofi: Euro regulators deem Lantus safe
Marketwatch
Thu, 07/23/09 - 03:54 pm
Sanofi
diabetes
Lantus
Byetta: The Blockbuster Around the Corner
Motley Fool
Wed, 07/22/09 - 03:03 pm
Byetta
diabetes
Amylin
Depomed licenses patents to Merck on diabetes drug
Marketwatch
Wed, 07/22/09 - 11:17 am
Merck
Depomed
licensing
diabetes
Sanofi Says Lantus Studies ‘Inconsistent’ and ‘Inconclusive’
Bloomberg
Wed, 07/15/09 - 09:35 am
Lantus
insulin
diabetes
Sanofi
Halozyme Begins Phase 2 Clinical Trial of Insulin-PH20 in Type 2 Diabetic Patients
Yahoo
Tue, 07/14/09 - 09:36 am
Halozyme
drug trials
insulin
diabetes
Total US Prescriptions For Sanofi's Lantus Rose Last Week
WSJ Online
Tue, 07/7/09 - 06:10 pm
Sanofi
diabetes
Lantus
Sanofi’s Lantus Didn’t Raise Blindness Risk in Study
Bloomberg
Mon, 07/6/09 - 09:17 am
Sanofi
Lantus
diabetes
Pages
« first
‹ previous
…
107
108
109
110
111
112
113
114
115
next ›
last »